Report overview
Anti-Parkinson Drugs are drugs used to treat Parkinson's disease.
This report contains market size and forecasts of Anti-Parkinson Drugs in Global, including the following market information:
Global Anti-Parkinson Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-Parkinson Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dopaminergic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Parkinson Drugs include AbbVie, Mylan Laboratories, Valeant Pharmaceuticals, Novartis, GlaxoSmithKline, Zambon Pharmaceuticals, Pfizer, Inc., Hoffmann-La Roche and Merck & Co., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Parkinson Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Parkinson Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-Parkinson Drugs Market Segment Percentages, by Type, 2021 (%)
Dopaminergic
Dopamine Agonists
Enzyme Inhibitors
Others
Global Anti-Parkinson Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-Parkinson Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Stores
Global Anti-Parkinson Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-Parkinson Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Parkinson Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-Parkinson Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Mylan Laboratories
Valeant Pharmaceuticals
Novartis
GlaxoSmithKline
Zambon Pharmaceuticals
Pfizer, Inc.
Hoffmann-La Roche
Merck & Co.
Orion Pharma
UCB
Teva Pharmaceutical Industries Ltd.
Vertical Pharmaceuticals, LLC
ACADIA Pharmaceuticals Inc.
